公司资料
Revelation Biosciences 股价、新闻与催化剂
- 股票代码:
- REVB
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股票表现
1.15 USD (+9.63%)
收盘价
最后更新: 2026年8月17日
4.14M USD
市值
股价为何变动
As of Aug 17, 2026, REVB closed up 9.63% at $1.15. No new same-company headline was identified in the current news window.
公司概览
业务概览
Revelation Biosciences is a biotechnology company focused on innate immunity and inflammation-linked disease biology. Its story centers on using immune modulation to address difficult inflammatory conditions.
所在地与行业分类
Revelation is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology with an immunology focus.
商业模式特征
The company depends on early clinical and preclinical progress, capital efficiency, and the ability to show that its platform can create differentiated value. Investors watch proof-of-concept data and financing runway.
生物医药行业定位
Revelation occupies a speculative immune-modulation niche within biotech. It is a small company where data quality and strategic focus dominate the stock.
未来催化剂
- Revelation’s catalysts are microbiome / inflammation programs and any update that shows the platform can still progress clinically. The company remains highly dependent on data.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。